Improved Efficacy of a Pegylated Interferon-α-2a Stepwise Optimization Treatment Strategy in the Treatment of Hepatitis B e Antigen-positive Chronic Hepatitis B Patients

Current pegylated interferon-α (PEG-IFN) treatment for chronic hepatitis B (CHB) e-antigen (HBeAg)-positive patients are suboptimal, and effective ways of improving PEG-IFN treatment efficacy are needed. This retrospective cohort study compared the efficacy of a PEG-IFN stepwise optimization treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Pu, Yang, Feifei, Wang, Jinyu, Mao, Richeng, Qi, Xun, Huang, Yuxian, Zhang, Jiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603052/
https://www.ncbi.nlm.nih.gov/pubmed/25929904
http://dx.doi.org/10.1097/MD.0000000000000730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603052/
https://www.ncbi.nlm.nih.gov/pubmed/25929904
http://dx.doi.org/10.1097/MD.0000000000000730

Ejemplares similares